AIM Biotech
  • HOME
    • ABOUT US
    • CAREERS
    • NEWSROOM
  • TECHNOLOGY
    • TECHNOLOGY
    • APPLICATIONS
    • PUBLICATIONS
  • PRODUCTS
    • CHIPS
    • ACCESSORIES
  • SERVICES
  • SUPPORT
    • PROTOCOLS >
      • GENERAL PROTOCOLS
      • APPLICATION-SPECIFIC PROTOCOLS
      • VIDEOS
      • PROTOCOL SUBMISSION
    • CONTACT US
    • FAQ
    • TIPS & TRICKS
    • BROCHURES
    • APPLICATION NOTES
    • FORUMS
  • STORE
    • DISTRIBUTORS

Dana-Farber researchers present posters at AACR 2017 with data using AIM chips

4/4/2017

0 Comments

 
Picture
Researchers from the Dana-Farber Cancer Institute presented two posters at AACR 2017: 
1. Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids (abstract linked 
here) 
2. Validation of a novel microfluidic device for screening of immune checkpoint inhibitors using 3D organotypic tumor spheroids (abstract linked
 here)

The researchers demonstrated that they could recapitulate sensitivity and innate resistance to PD-1 blockade ex vivo with an assay developed on AIM chips. They were able to profile the functional response to tumor PD-1 blockade ex vivo and unveil a novel strategy to advance precision immuno-oncology. ​
0 Comments



Leave a Reply.

    Archives

    January 2020
    December 2019
    November 2018
    October 2018
    August 2018
    July 2018
    April 2018
    November 2017
    July 2017
    April 2017
    December 2016
    July 2016
    March 2016
    January 2016
    December 2015
    September 2015
    August 2015

    Categories

    All

    RSS Feed

Picture
About AIM Biotech
Contact Us
Newsroom
Subscribe to AIM Biotech's mailing list

This website and its content is copyright of AIM Biotech Pte. Ltd.
​© AIM Biotech Pte. Ltd. 2020. All rights reserved.